Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01491516
Other study ID # P01-07
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2003
Est. completion date October 2008

Study information

Verified date December 2011
Source Medtronic Spinal and Biologics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot study is to evaluate the feasibility of the implant ( TELAMON P™ Implant/INFUSE Bone Graft System used in conjunction with the CD HORIZON® Spinal System) as a method of facilitating lumbar spinal fusion utilizing a posterior surgical approach in patients with symptomatic degenerative disc disease. The safety and effectiveness of the implant will be evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 2008
Est. primary completion date April 2008
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. Has degenerative disc disease as noted by back pain of discogenic origin, with or without leg pain, with degeneration of the disc confirmed by patient history and radiographic studies to include one or more of the following:

- instability (defined as angulation >= 5° and/or translation >= 4mm, based on flexion/extension radiographs);

- osteophyte formation;

- decreased disc height;

- thickening of ligamentous tissue;

- disc degeneration or herniation; and/or

- facet joint degeneration.

2. Has preoperative Oswestry score >= 30.

3. Has preoperative back pain score of >= 25 based on the Preoperative Back and Leg Pain Questionnaire (intensity and duration).

4. Has no greater than Grade 1 spondylolisthesis utilizing Meyerding's Classification (Meyerding, HW, 1932).

5. Requires fusion of a single level disc space from L 1 to S 1.

6. Is at least 18 years of age, inclusive, at the time of surgery.

7. Has not responded to non-operative treatment for a period of 6 months.

8. If of child-bearing potential, patient is non-pregnant, non-nursing, and agrees to not get pregnant for 1 year following surgery.

9. Is willing and able to comply with the study plan and sign the Patient Informed Consent Form.

Exclusion Criteria:

1. Has primary diagnosis of a spinal disorder other than degenerative disc disease with Grade 1 or less spondylolisthesis at the involved level.

2. Had previous spinal fusion surgical procedure at the involved level.

3. Requires spinal fusion at more than one lumbar level.

4. Has a condition which requires postoperative medications that interfere with fusion, such as steroids or prolonged use of nonsteroidal anti-inflammatory drugs excluding routine peri-operative nonsteroidal anti-inflammatory drugs. This does not include low dose aspirin for prophylactic anticoagulation.

5. Has been previously diagnosed with osteopenia or osteomalacia.

6. Has any of the following that may be associated with a diagnosis of osteoporosis (if "Yes" to any of the below risk factors, a dual x-ray absorptiometry (DEXA) Scan will be required to determine eligibility).

1. Postmenopausal Non-Black female over 60 years of age and weighs less than 140 pounds.

2. Postmenopausal female that has sustained a non-traumatic hip, spine, or wrist fracture.

3. Male over the age of 70.

4. Male over the age of 60 that has sustained a non-traumatic hip or spine fracture. If the level of BMD is a T score of -3.5 or a T score of -2.5 with vertebral crush fracture, the patient is excluded from the study.

7. Has presence of active malignancy or prior history of malignancy, except for basal cell carcinoma of the skin.

8. Has an overt or active bacterial infection, either local or systemic.

9. Has a documented titanium, titanium alloy, tantalum, tantalum alloy, or polyetheretherketone allergy or intolerance.

10. Is mentally incompetent. If questionable, obtain psychiatric consult.

11. Has a Waddell Signs of Inorganic Behavior score of 3 or greater.

12. Is a prisoner.

13. Is an alcohol and/or drug abuser as defined by currently undergoing treatment for alcohol and/or drug abuse.

14. Has received drugs which may interfere with bone metabolism within two weeks prior to the planned date of spinal fusion surgery (e.g., steroids or methotrexate), excluding routine perioperative antiinflammatory drugs.

15. Has a history of any autoimmune disease (e.g. Systemic Lupus Erythematosus or Dermatomyositis) .

16. Has a history of exposure to injectable collagen or silicone implants.

17. Has a history of hypersensitivity to protein pharmaceuticals (e.g. monoclonal antibodies or gamma globulins) or collagen.

18. Has received treatment with an investigational therapy (device and/or pharmaceutical) within 28 days prior to implantation surgery or such treatment is planned during the 16 weeks following the investigational treatment.

19. Has received any previous exposure to any/all BMP's of either human or animal extraction.

20. Has a history of allergy to bovine products or a history of anaphylaxis.

21. Has history of any endocrine or metabolic disorder known to affect osteogenesis (e.g., Paget's disease, renal osteodystrophy, Ehlers-Danlos syndrome, or osteogenesis imperfecta).

Study Design


Intervention

Device:
TELAMON P™ /INFUSE® Bone Graft/CD HORIZON® Spinal System
The TELAMON P™/INFUSE™ Bone Graft Implant in conjunction with the CD HORIZON® Spinal System for single level lumbar fusion from L1 to S1

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Medtronic Spinal and Biologics

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Success A patient will be considered an overall success if all of the following conditions are met:
fusion;
pain/disability (Oswestry) success;
neurological status success;
no serious adverse event classified as "implant associated" or "implant/surgical procedure associated";
no additional surgical procedure classified as a "failure".
24 month
Secondary Disc Height Measurement 24 month
Secondary General Health Status (SF-36) 24 month
Secondary Pain Status (back pain, leg pain) 24 month
Secondary Patient Satisfaction 24 month
Secondary Patient Global Perceived Effect 24 month
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Completed NCT04057235 - Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Active, not recruiting NCT02969616 - Trinity Elite in Lumbar Fusion
Completed NCT02558621 - New Robotic Assistance System for Spinal Fusion Surgery N/A
Completed NCT02104167 - Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Completed NCT00965380 - Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Completed NCT00758719 - Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
Completed NCT00165893 - Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease Phase 4
Terminated NCT01494493 - Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04849429 - Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain Phase 1
Recruiting NCT04469387 - Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion N/A
Recruiting NCT04056520 - Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System
Completed NCT04119466 - Stabilizing Training in Degenerative Disc Disease N/A